Dry eye
Conditions
Interventions
Diquafosol Sodium ophthalmic solution 3%
Artificial tear MYTEAR ophthalmic solution
Sponsors
Miyake Eye Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: To have a plan to be given an age-related cataract surgery (confine to phacoemulsification and aspiration, any incision). Patients who are diagnosed as definite or probable dry eye by Dry Eye Diagnostic Criteria (study eye). Corneal and conjunctival staining is 1 or more than 1 point(study eye)
Exclusion criteria
Exclusion criteria: Patients who have allergic conjunctivitis and have possibilities to get worse during study phase. Patients who have glaucoma and uveitis requiring treatment. (study eye) Histories of Lasik, blepharoplasty, ocular injury or corneal transplants. (study eye) Patients who have diabetic retinopathy. (study eye) History of allogeneic heamatopoietic stem cell transplantation. Known allergy to any drug to be used during study phase. Patients who had a continued use of eye drops for dry eye within 2 weeks before this study. (study eye) Patients who had a punctal plug (study eye) Plans to use a prohibited concomitant drug during study phase. (study eye) Plans to receive prohibited concurrent therapy during study phase. (study eye) Those who need to wear contact lenses during study phase. (study eye) Cannot make the specified hospital visits. The investigator/subinvestigator has judged that the patient is ineligible as study subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence rate of dry eye after cataract surgery. Tear film breakup time (BUT). Corneal and conjunctival staining score. Subjective symptoms (12 items). Adverse event and side effect. | — |
Countries
Japan
Contacts
Public ContactKensaku Miyake
Miyake Eye Hospital No
Outcome results
None listed